Company / Current Assets
Haemonetics Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$935.0M
FY2025
5-year range
$693.5M / $935.0M
FY2021-FY2025
Trend
+21.6%
vs FY2024
Sector context
#82 of 165
Health Care
What the data says
At $935M, Haemonetics's current assets ranks #82 of 165 in the Health Care sector. Improved from $770M to $935M over the past 2 years.
Based on SEC 10-K filings.
$935M in FY2025 with a 5-year CAGR of +9.1%.
Improved from $770M to $935M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +7.3%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
#82 of 165 in Health CareTop 50% of 165This company $935.0M Sector average $5.2B
▼
-82.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.1%, indicating consistent growth.
- In FY2025, current assets increased 21.6% year-over-year.
- Ranks #82 out of 165 companies in the Health Care sector.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $935.0M | +21.6% |
| FY2024 | $768.9M | -0.1% |
| FY2023 | $769.7M | +1.8% |
| FY2022 | $756.0M | +9.0% |
| FY2021 | $693.5M | +14.9% |
| FY2020 | $603.6M | +4.8% |
| FY2019 | $576.1M | +10.5% |
| FY2018 | $521.2M | +2.2% |
| FY2017 | $510.0M | +4.5% |
| FY2016 | $488.1M | -12.5% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026